Structural and biochemical basis of ROC-dependent activation of LRRK2.
Using cryo-EM, X-ray crystallography, and biochemical perturbations, the paper reveals that monomeric full-length LRRK2 adopts three intrinsic conformations (autoinhibited, intermediate, activated) and that ROC GTPase switch-region plasticity—specifically coupling between R1441 and switch…
What the AI sees
Using cryo-EM, X-ray crystallography, and biochemical perturbations, the paper reveals that monomeric full-length LRRK2 adopts three intrinsic conformations (autoinhibited, intermediate, activated) and that ROC GTPase switch-region plasticity—specifically coupling between R1441 and switch…
Research significance
High-resolution mechanistic and structural mapping of ROC-dependent activation identifies specific allosteric nodes (switch regions and R1441 coupling) that are actionable targets for rational design of modulators to normalize aberrant LRRK2 activity in Parkinson's disease.
Source abstract
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease, yet the molecular mechanism governing LRRK2 activation remains incompletely understood. LRRK2 is a large multidomain enzyme whose kinase activity is regulated by intramolecular interactions and by its Ras of complex proteins (ROC) GTPase domain. Here, we combine cryo-electron microscopy, X-ray crystallography, and structure-guided biochemical perturbations to define how ROC conformational switching regulates LRRK2 activation. Cryo-EM reconstructions reveal that monomeric full-length LRRK2 samples three distinct conformational states-autoinhibited, intermediate, and activated-indicating that large-scale activation-associated rearrangements can occur through an intrinsic intramolecular pathway, independently of Rab29 binding, higher-order oligomerization, or membrane association. A 1.6-Å crystal structure of an extended ROC construct reveals intrinsic conformational plasticity within the GTPase switch regions that likely underlies these transitions. Structure-guided disulfide engineering identifies a functional coupling between residue R1441 and switch II that directly modulates GTPase activity in both isolated ROC and full-length LRRK2. Disruption of this coupling phenocopies the disease-associated R1441H mutation. Together, these findings establish ROC as a dynamic conformational engine that drives a multistep intramolecular activation mechanism in LRRK2, providing mechanistic insight into how pathogenic mutations promote aberrant kinase activation.